What does this research mean for the field?

Pharmacist-led discharge medication reconciliation reduces 30-day hospital readmissions and generates significant healthcare cost savings. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

To evaluate the impact of pharmacist-led discharge medication reconciliation on 30-day hospital readmission odds and financial outcomes following the launch of a transitions-of-care service.

September 5, 2026Hospital PharmacyOpen Access

Optimizing Transitions of Care: The Impact of Pharmacist-Led Discharge Interventions on Readmissions and Healthcare Costs

Q: What is the clinical evidence from this study?

Study design: Observational. Population: Hospital discharge (n=12367). Intervention: Pharmacist-led discharge medication reconciliation vs. No pharmacist-led discharge medication reconciliation. Primary outcome: 30-day hospital readmission odds (OR 1.06, 95% CI 1.00-1.11, p=.036).

View Full Paper

Ask AI

Bookmark

Key result

Lack of pharmacist-led discharge medication reconciliation is linked to ~6% higher 30-day readmission odds.

OR 1.06
95% CI 1.00-1.11
P=.036
n=12,367

Why the study?

Medication discrepancies at hospital discharge contribute to readmissions and adverse outcomes, but implementation of recommended pharmacist-led discharge medication reconciliation varies.

Does pharmacist-led discharge medication reconciliation reduce 30-day hospital readmission odds in discharged in-patients?

Population

12 367 discharged in-patients at a quaternary medical center

Comparison

Pharmacist-led discharge medication reconciliation vs no pharmacist reconciliation

Design

Retrospective observational study

Follow-up

30 days

Authors

OKOmar El KhatibAbu Dhabi Health Services WNWasim S. El NekidyAbu Dhabi University EAEmna AbidiCleveland Clinic

Discussion

Member takes

Implication

May support pharmacist-led discharge reconciliation to reduce readmissions; extends observational data but leaves causal effects open.

Key Points

To evaluate the impact of pharmacist-led discharge medication reconciliation on 30-day hospital readmission odds and financial outcomes following the launch of a transitions-of-care service.
Retrospective observational study at a quaternary medical center evaluating 12,367 eligible inpatient discharges (excluding intensive care, oncology, and transplant services).
Compared patients who received pharmacist-led discharge medication reconciliation (n = 8,469) against those who did not.
Used generalized estimating equations accounting for repeated encounters and case mix index interaction to evaluate 30-day readmission odds and documented cost avoidance.
Not receiving pharmacist-led discharge medication reconciliation was associated with significantly increased odds of 30-day readmission (OR, 1.06; 95% CI, 1.00–1.11; P = .036).
Digestive Diseases Institute patients without the intervention had higher readmission odds initially (OR, 2.14; 95% CI, 1.14–3.99; P = .017), which became non-significant after adjusting for case mix index interaction (OR, 1.47; 95% CI, 0.52–4.19; P = .467).
Pharmacists performed 437 documented clinical interventions during discharge reconciliation in 2024, yielding an estimated $240,448.77 in healthcare cost avoidance.

Study Design

Type

Observational (n=12,367)

Multicenter

Structured PICO

Does pharmacist-led discharge medication reconciliation reduce 30-day hospital readmission odds in discharged in-patients?

Population

12,367 discharged in-patients (excluding intensive care, oncology, and transplant services) evaluated for 30-day hospital readmission.

Exposure

Pharmacist-led discharge medication reconciliation

Comparator

No pharmacist-led discharge medication reconciliation

Outcome

30-day hospital readmission oddshard clinical

Main Result

Odds Ratio: 1.06 (95% CI 1–1.11)

p-value: p=.036

Pharmacist-led discharge medication reconciliation significantly reduces 30-day hospital readmissions and provides substantial cost savings.

Cite This Study

Khatib et al. (2026) conducted an observational in Hospital discharge (n=12,367). Pharmacist-led discharge medication reconciliation vs. No pharmacist-led discharge medication reconciliation was evaluated on 30-day hospital readmission odds (OR 1.06, 95% CI 1.00-1.11, p=.036). Lack of pharmacist-led discharge medication reconciliation was associated with significantly greater odds of 30-day hospital readmission (OR 1.06; 95% CI 1.00-1.11; P=0.036).

synapsesocial.com/papers/6a9bd49d6b95aff0620ec5f4 https://doi.org/10.1177/00185787261470576

View Full Paper

Ask AI

Bookmark

Optimizing Transitions of Care: The Impact of Pharmacist-Led Discharge Interventions on Readmissions and Healthcare Costs

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Main Result

Cite This Study

Optimizing Transitions of Care: The Impact of Pharmacist-Led Discharge Interventions on Readmissions and Healthcare Costs

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Main Result

Cite This Study

Also Consider

Also Consider